$NVOS
Novo Integrated Sciences, Inc. Stock $nvos

$nvos Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224003195 Filed on January 22, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$3.171M	$3.891M	$3.419M
YoY Change	24.02%	13.8%	8.14%
Cost Of Revenue	$1.847M	$1.947M	$1.680M
YoY Change	16.45%	15.92%	-11.38%
Gross Profit	$1.324M	$1.944M	$1.740M
YoY Change	36.38%	11.76%	37.35%
Gross Profit Margin	41.76%	49.96%	50.87%
Selling, General & Admin	$2.864M	$5.262M	$3.981M
YoY Change	3.85%	32.15%	51.38%
% of Gross Profit	216.29%	270.66%	228.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$568.2K	$72.60K	$60.04K
YoY Change	2.82%	20.92%	-91.35%
% of Gross Profit	42.91%	3.73%	3.45%
Operating Expenses	$2.864M	$5.262M	$3.981M
YoY Change	3.85%	32.15%	51.38%
Operating Profit	-$1.540M	-$3.318M	-$2.242M
YoY Change	-13.83%	47.98%	64.41%
Interest Expense	-$897.0K	-$690.9K	$167.2K
YoY Change	-824.19%	-513.12%	-136.94%
% of Operating Profit
Other Income/Expense, Net	-$308.8K	-$1.343M	-$1.695M
YoY Change	-89.2%	-20.75%	274.34%
Pretax Income	-$2.746M	-$4.661M	-$3.937M
YoY Change	-40.89%	18.39%	116.73%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$2.746M	-$4.680M	-$3.935M
YoY Change	-40.58%	18.93%	116.66%
Net Earnings / Revenue	-86.61%	-120.28%	-115.09%
Basic Earnings Per Share	-$0.16	-$0.28	-$0.12
Diluted Earnings Per Share	-$0.16	-$0.28	-$0.12
COMMON SHARES
Basic Shares Outstanding	17.75M shares	17.29M shares	33.86M shares
Diluted Shares Outstanding	17.64M shares	16.73M shares	3.386M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$651.8K	$1.640M	$878.7K
YoY Change	6.89%	86.64%	-90.02%
Cash & Equivalents	$651.8K	$1.640M	$878.7K
Short-Term Investments
Other Short-Term Assets	$217.6K	$213.8K	$555.0K
YoY Change	-60.19%	-61.47%	110.86%
Inventory	$947.4K	$1.271M	$1.010M
Prepaid Expenses
Receivables	$2.154M	$2.636M	$960.1K
Other Receivables	$1.049M	$1.048M	$1.053M
Total Short-Term Assets	$5.019M	$6.809M	$4.457M
YoY Change	23.91%	52.75%	-63.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.163M	$5.307M	$5.564M
YoY Change	31.45%	-4.62%	-34.87%
Goodwill	$7.561M	$7.555M	$7.596M
YoY Change	0.28%	-0.54%
Intangibles	$15.21M	$15.70M
YoY Change	-11.59%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$29.93M	$30.44M	$33.29M
YoY Change	-7.73%	-8.58%	-35.6%
TOTAL ASSETS
Total Short-Term Assets	$5.019M	$6.809M	$4.457M
Total Long-Term Assets	$29.93M	$30.44M	$33.29M
Total Assets	$34.95M	$37.24M	$37.75M
YoY Change	-4.22%	-1.34%	-40.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.174M	$3.404M	$2.075M
YoY Change	6.55%	64.02%	57.81%
Accrued Expenses	$2.224M	$1.301M	$1.233M
YoY Change	81.84%	5.52%	-44.57%
Deferred Revenue		$35.07K	$35.78K
YoY Change		-1.99%
Short-Term Debt	$2.208M	$1.562M	$6.840M
YoY Change	147.97%	-77.16%	316.75%
Long-Term Debt Due	$1.014M	$1.016M	$8.740K
YoY Change	-0.6%	11523.23%	-99.91%
Total Short-Term Liabilities	$9.959M	$10.92M	$12.57M
YoY Change	61.2%	-13.13%	-19.73%
LONG-TERM LIABILITIES
Long-Term Debt	$64.02K	$63.78K	$1.086M
YoY Change	-1.48%	-94.13%	-5.93%
Other Long-Term Liabilities	$1.639M	$1.586M	$2.010M
YoY Change	-13.29%	-21.11%	1.56%
Total Long-Term Liabilities	$1.703M	$1.649M	$3.096M
YoY Change	-12.9%	-46.72%	-1.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.959M	$10.92M	$12.57M
Total Long-Term Liabilities	$1.703M	$1.649M	$3.096M
Total Liabilities	$12.76M	$13.96M	$17.06M
YoY Change	33.95%	-18.19%	-15.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$74.46M	-$71.71M	-$57.75M
YoY Change	19.37%	24.17%
Common Stock	$17.75K	$17.29K	$39.89K
YoY Change	-87.29%	-56.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.19M	$23.58M	$20.95M
YoY Change
Total Liabilities & Shareholders Equity	$34.95M	$37.24M	$37.75M
YoY Change	-4.22%	-1.34%	-40.96%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	-$2.746M	-$4.680M	-$3.935M
YoY Change	-40.58%	18.93%	116.66%
Depreciation, Depletion And Amortization	$568.2K	$72.60K	$60.04K
YoY Change	2.82%	20.92%	-91.35%
Cash From Operating Activities	-$1.714M	-$2.152M	-$278.2K
YoY Change	95.04%	673.57%	-63.35%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change			-100.0%
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.795M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.190K	$3.296M	-$1.034M
YoY Change	-99.26%	-418.78%	-173.87%
NET CHANGE
Cash From Operating Activities	-1.714M	-$2.152M	-$278.2K
Cash From Investing Activities
Cash From Financing Activities	3.190K	$3.296M	-$1.034M
Net Change In Cash	-1.710M	$1.224M	-$1.300M
YoY Change	280.71%	-194.13%	-336.54%
FREE CASH FLOW
Cash From Operating Activities	-$1.714M	-$2.152M	-$278.2K
Capital Expenditures
Free Cash Flow			-$278.2K
YoY Change			-56.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-31
CY2023Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001138978
CY2023Q3	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022Q4	NVOS	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability		usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	NVOS	Issuance Of Common Stock To Be Issued IssuanceOfCommonStockToBeIssued		shares
CY2023Q4	NVOS	Stock Issued During Period Value Stock Splits StockIssuedDuringPeriodValueStockSplits		usd
CY2022Q4	NVOS	Issuance Of Common Stock To Be Issued IssuanceOfCommonStockToBeIssued		shares
CY2023Q4	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions		usd
CY2022Q4	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2022Q4	NVOS	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability		usd
CY2022Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022Q4	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2023Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q4	NVOS	Common Stock Issued For Convertible Debt Settlement CommonStockIssuedForConvertibleDebtSettlement		usd
CY2022Q4	NVOS	Debt Discount Recognized On Convertible Note DebtDiscountRecognizedOnConvertibleNote		usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2023Q4	NVOS	Other Receivable Write Offs OtherReceivableWriteOffs		usd
CY2023	NVOS	Other Receivable Write Offs OtherReceivableWriteOffs		usd
CY2023Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2023Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2023Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2023Q4	NVOS	Capital Expenditures CapitalExpenditures		usd
CY2022Q4	NVOS	Capital Expenditures CapitalExpenditures		usd
CY2023Q4	dei	Document Type DocumentType	10-Q
CY2023Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q4	dei	Document Period End Date DocumentPeriodEndDate	2023-11-30
CY2023Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q4	dei	Entity File Number EntityFileNumber	001-40089
CY2023Q4	dei	Entity Registrant Name EntityRegistrantName	Novo Integrated Sciences, Inc.
CY2023Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	59-3691650
CY2023Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	11120 NE 2nd Street
CY2023Q4	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2023Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	Bellevue
CY2023Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2023Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98004
CY2023Q4	dei	City Area Code CityAreaCode	(206)
CY2023Q4	dei	Local Phone Number LocalPhoneNumber	617-9797
CY2023Q3	NVOS	Contingent Liabilities Current ContingentLiabilitiesCurrent	61767	usd
CY2023Q4	NVOS	Debentures Related Parties DebenturesRelatedParties	913474	usd
CY2023Q3	NVOS	Debentures Related Parties DebenturesRelatedParties	916824	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8907	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	11744	usd
CY2023Q4	dei	Security12b Title Security12bTitle	Common Stock
CY2023Q4	dei	Trading Symbol TradingSymbol	NVOS
CY2023Q4	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q4	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q4	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17748320	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1640007	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	416323	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2636174	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1467028	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1270835	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	1106983	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1047742	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1051584	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	213812	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	346171	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	6808570	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	4388089	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5306613	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5390038	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15704218	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	16218539	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1870204	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1983898	usd
CY2023Q4	us-gaap	Goodwill Goodwill	7554779	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7582483	usd
CY2023Q4	us-gaap	Assets Assets	37244384	usd
CY2023Q3	us-gaap	Assets Assets	35563047	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3403634	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3513842	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1300549	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1233549	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	480719	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	382666	usd
CY2023Q4	NVOS	Notes And Loan Payable Current NotesAndLoanPayableCurrent	93488	usd
CY2023Q3	NVOS	Notes And Loan Payable Current NotesAndLoanPayableCurrent	277405	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	3118819	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	3118819	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1103959	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	558668	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2686260	usd
CY2023Q4	NVOS	Contingent Liabilities Current ContingentLiabilitiesCurrent	52749	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	413506	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	415392	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10915511	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7904858	usd
CY2023Q4	NVOS	Long Term Notes And Loan LongTermNotesAndLoan	63777	usd
CY2023Q3	NVOS	Long Term Notes And Loan LongTermNotesAndLoan	65038	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1585667	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1693577	usd
CY2023Q4	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	1395381	usd
CY2023Q3	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	1400499	usd
CY2023Q4	us-gaap	Liabilities Liabilities	13960336	usd
CY2023Q3	us-gaap	Liabilities Liabilities	11063972	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17291192	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17291192	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15759325	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15759325	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	17292	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	15760	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	95481354	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	90973316	usd
CY2023Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	17375	shares
CY2023Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	91138	shares
CY2023Q4	NVOS	Common Stock Subscribed But Unissued Subscriptions Receivable CommonStockSubscribedButUnissuedSubscriptionsReceivable	44443	usd
CY2023Q3	NVOS	Common Stock Subscribed But Unissued Subscriptions Receivable CommonStockSubscribedButUnissuedSubscriptionsReceivable	1217293	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-246488	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-357383	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-71713384	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67033041	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	23583217	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	24815945	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-299169	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	-316870	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23284048	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24499075	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37244384	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35563047	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3891218	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3419280	usd
CY2023Q4	us-gaap	Cost Of Revenue CostOfRevenue	1947200	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	1679747	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	1944018	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	1739533	usd
CY2023Q4	us-gaap	Selling Expense SellingExpense	9586	usd
CY2022Q4	us-gaap	Selling Expense SellingExpense	7332	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5252069	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3974161	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	5261655	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	3981493	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-3317637	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2241960	usd
CY2023Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	2219	usd
CY2022Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	2281	usd
CY2023Q4	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	143374	usd
CY2022Q4	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	167243	usd
CY2023Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-652174	usd
CY2023Q4	NVOS	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	-585529	usd
CY2023Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1075928	usd
CY2022Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1490513	usd
CY2023Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-59358	usd
CY2022Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-39301	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1343086	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1694776	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4660723	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3936736	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-4660723	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-3936736	usd
CY2023Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	19620	usd
CY2022Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1323	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-4680343	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3935413	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-4660723	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-3936736	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	108976	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-420982	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4551747	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4357718	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16726308	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16726308	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3385508	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3385508	shares
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.16
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.16
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24499075	usd
CY2023Q4	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	1323398	usd
CY2023Q4	NVOS	Stock Issued During Period Value Exercise Of Warrants For Cash StockIssuedDuringPeriodValueExerciseOfWarrantsForCash	240400	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	577522	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1195400	usd
CY2023Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	108976	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-4660723	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23284048	usd
CY2022Q4	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	1139050	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	60887	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22047571	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22047571	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1795000	usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	240400	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3296272	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1034021	usd
CY2023Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	79770	usd
CY2022Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-420982	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-3936736	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-3936736	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20684790	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20684790	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-4660723	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-3936736	usd
CY2023Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	572404	usd
CY2022Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	586166	usd
CY2022Q4	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions	-60887	usd
CY2023Q4	NVOS	Financing Costs For Debt Extension FinancingCostsForDebtExtension	-1323398	usd
CY2022Q4	NVOS	Financing Costs For Debt Extension FinancingCostsForDebtExtension	-1139050	usd
CY2023Q4	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1195400	usd
CY2023Q4	us-gaap	Operating Lease Expense OperatingLeaseExpense	149877	usd
CY2022Q4	us-gaap	Operating Lease Expense OperatingLeaseExpense	209846	usd
CY2023Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1075928	usd
CY2022Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1490513	usd
CY2023Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-59358	usd
CY2022Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-39301	usd
CY2023Q4	NVOS	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	-585529	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1168350	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-28174	usd
CY2023Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	166476	usd
CY2022Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	157118	usd
CY2023Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-130584	usd
CY2022Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1471	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-98996	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	321961	usd
CY2023Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	71214	usd
CY2022Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	149945	usd
CY2023Q4	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	99430	usd
CY2022Q4	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-9232	usd
CY2023Q4	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-149877	usd
CY2022Q4	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-202465	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2152358	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-278237	usd
CY2023Q4	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-72402	usd
CY2022Q4	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-48480	usd
CY2023Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	183100	usd
CY2023Q4	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2779	usd
CY2022Q4	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2763	usd
CY2023Q4	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3314153	usd
CY2022Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2777778	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1795000	usd
CY2022Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12271	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1223684	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1299987	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	416323	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2178687	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1640007	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	878700	usd
CY2023Q4	us-gaap	Interest Paid Net InterestPaidNet	45321	usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet	186911	usd
CY2023Q4	NVOS	Debt Discount Recognized On Derivative Liability DebtDiscountRecognizedOnDerivativeLiability	3071653	usd
CY2022Q4	NVOS	Debt Discount Recognized On Derivative Liability DebtDiscountRecognizedOnDerivativeLiability	1390380	usd
CY2023Q4	NVOS	Common Stock Issued For Convertible Debt Settlement CommonStockIssuedForConvertibleDebtSettlement	577522	usd
CY2023Q4	NVOS	Debt Discount Recognized On Convertible Note DebtDiscountRecognizedOnConvertibleNote	3735414	usd
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2023Q4	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_z0fpboaceMqc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_868_zPN9H1Nf9MP4">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. This applies in particular to the going concern assessment, useful lives of non-current assets, impairment of non-current assets, allowance for doubtful receivables, allowance for slow moving and obsolete inventory, valuation of share-based compensation and warrants, valuation of derivative liability, and valuation allowance for deferred tax assets. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p>
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	6469	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	37900	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	157265	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	855116	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	864215	usd
CY2023Q4	NVOS	Schedule Of Intangible Assets Amortized Estimated Useful Lives ScheduleOfIntangibleAssetsAmortizedEstimatedUsefulLives	<p id="xdx_892_ecustom--ScheduleOfIntangibleAssetsAmortizedEstimatedUsefulLives_zCmnp02OBki" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company’s intangible assets are being amortized over their estimated useful lives as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span><span id="xdx_8B1_zdZ5SWXQ2NLb" style="display: none">Schedule of Intangible Assets Amortized Estimated Useful Lives</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Land use rights</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LandUseRightsMember_zrbXWsCvDz43" title="Intangible assets, estimated lives">50</span> years (the lease period)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Intellectual property</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zcnsUXsWQNwj" title="Intangible assets, estimated lives">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Customer relationships</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zkUJsQDfoEO5" title="Intangible assets, estimated lives">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Brand names</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231130__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zNAzYx2mkiEl" title="Intangible assets, estimated lives">7</span> years</span></td></tr> </table>
CY2023Q4	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023Q4	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3491290	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2331243	usd
CY2023Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
CY2022Q3	us-gaap	Goodwill Goodwill	7825844	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-243361	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7582483	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7582483	usd
CY2023Q4	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-27704	usd
CY2023Q4	us-gaap	Goodwill Goodwill	7554779	usd
CY2023Q4	us-gaap	Goodwill Goodwill	7554779	usd
CY2023Q4	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_84E_eus-gaap--DerivativesReportingOfDerivativeActivity_z8fMUTcqHhrf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_869_zEhHBau82nb1">Derivative Financial Instruments </span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments and measurement of their fair value for accounting purposes. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt under ASC 470, the Company will continue its evaluation process of these instruments as derivative financial instruments under ASC 815. The Company applies the guidance in ASC 815-40-35-12 to determine the order in which each convertible instrument would be evaluated for derivative classification.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to the fair value of derivatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	855116	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	864215	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	108976	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	922609	usd
CY2023Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	integer
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2636174	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1467028	usd
CY2021Q4	us-gaap	Share Price SharePrice	33.50
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	22388	shares
CY2021Q4	us-gaap	Share Price SharePrice	33.50
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1875000	usd
CY2023Q4	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zAt6CYP9bqy9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_866_zQdjfyskgOgk">Reclassifications</span> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Certain prior period amounts were reclassified to conform to the manner of presentation in the current period. These reclassifications had no effect on the net loss or shareholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p>
CY2023Q4	NVOS	Trade Receivables TradeReceivables	3412783	usd
CY2023Q3	NVOS	Trade Receivables TradeReceivables	2223243	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	78507	usd
CY2023Q3	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	108000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	516811	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	388391	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	108244	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	81696	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	645780	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	636896	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	1270835	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	1106983	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1270835	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	1106983	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	1047742	usd
CY2023Q3	us-gaap	Other Receivables OtherReceivables	1051584	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1047742	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1051584	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1820324	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1454624	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1208004	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	639025	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	8578655	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15704218	usd
CY2021Q4	NVOS	Shares Adjustment Description SharesAdjustmentDescription	The warrants expire on November 17, 2024. The Company first determined the value of the $1.875m convertible notes and the fair value of the detachable warrants issued in connection with this transaction.
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	351240	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6619035	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6643247	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1312422	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1253209	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5306613	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5390038	usd
CY2023Q4	us-gaap	Depreciation Depreciation	72604	usd
CY2022Q4	us-gaap	Depreciation Depreciation	60043	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23269852	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23290546	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7565634	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7072007	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15704218	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16218539	usd
CY2023Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	499800	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	526123	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2003586	usd
CY2023Q4	NVOS	Accrued Liabilities Gross Current AccruedLiabilitiesGrossCurrent	1049543	usd
CY2023Q3	NVOS	Accrued Liabilities Gross Current AccruedLiabilitiesGrossCurrent	961897	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	215936	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	236218	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	35070	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	35434	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1300549	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1233549	usd
CY2023Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	157265	usd
CY2023Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	342443	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	93488	usd
CY2023Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	277405	usd
CY2023Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	63777	usd
CY2023Q3	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	65038	usd
CY2023Q4	NVOS	Debt Instrument Default Repayment Percentage DebtInstrumentDefaultRepaymentPercentage	0.75	pure
CY2023Q4	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.05	pure
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	93488	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	6470	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	6469	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6469	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-24-003195-index-headers.html	Edgar Link	pending
0001493152-24-003195-index.html	Edgar Link	pending
0001493152-24-003195.txt	Edgar Link	pending
0001493152-24-003195-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nvos-20231130.xsd	Edgar Link	pending
nvos-20231130_cal.xml	Edgar Link	unprocessable
nvos-20231130_pre.xml	Edgar Link	unprocessable
nvos-20231130_def.xml	Edgar Link	unprocessable
nvos-20231130_lab.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVOS
Novo Integrated Sciences, Inc. Stock $nvos

2024 Q1 Form 10-Q Financial Statement

#000149315224003195 Filed on January 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVOS Novo Integrated Sciences, Inc. Stock $nvos

2024 Q1 Form 10-Q Financial Statement

#000149315224003195 Filed on January 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVOS
Novo Integrated Sciences, Inc. Stock $nvos